Travel with NAD+ Airplane TSA — What Researchers Need to

Travel with NAD+ Airplane TSA — What Researchers Need to Know

Fewer than 30% of researchers travelling with peptides properly maintain cold chain integrity during air travel. And TSA checkpoint confusion accounts for most storage failures. The problem isn't TSA confiscating your NAD+ (nicotinamide adenine dinucleotide); it's researchers packing lyophilised peptides in checked luggage where cabin temperatures fluctuate wildly, or failing to declare reconstituted vials at security, forcing last-minute repacking that breaks refrigeration. A single three-hour temperature excursion above 8°C can degrade NAD+ potency by 15–40%, and no visual inspection will tell you it happened.

Our team works directly with researchers who travel internationally with peptide compounds. The gap between doing this correctly and losing an entire research batch comes down to three things most packing guides never mention: TSA's medication exception rules, how to document research-grade compounds that aren't prescription drugs, and which cooling systems actually maintain 2–8°C for intercontinental flights.

Can you travel with NAD+ on an airplane through TSA?

Yes. NAD+ peptides are permitted through TSA checkpoints when carried as research materials or under prescription exemption, provided they are declared at security, properly labelled with your name and prescriber information (if applicable), and maintained within required temperature ranges using TSA-compliant cooling systems. Lyophilised (freeze-dried) NAD+ powder tolerates brief ambient exposure better than reconstituted liquid, but both require documentation and cold storage to preserve research integrity across flights exceeding four hours.

Direct Answer: What TSA Actually Checks

TSA does not treat research peptides the same way it treats prescription medications. And this distinction matters because it determines what documentation you need. Prescription medications receive automatic exemption from the 3.4-ounce liquid rule under TSA's medical necessity provision; research-grade peptides like NAD+ do not automatically qualify unless accompanied by prescriber documentation or institutional research authorisation.

The confusion arises because NAD+ exists in both contexts: some researchers carry prescriber-authorised NAD+ for personal therapeutic use (which qualifies as medication), while others carry research-grade NAD+ purchased from suppliers like Real Peptides for laboratory work (which requires institutional documentation). TSA officers cannot distinguish between these uses by visual inspection alone. Your documentation determines how the checkpoint proceeds. This article covers exactly how to prepare that documentation, which cooling systems pass TSA screening without delays, and what to do if a TSA officer questions your peptide vials at security.

TSA Rules for Research Peptides vs Prescription Medications

TSA Policy 3-1-1 exempts medically necessary liquids from the standard 3.4-ounce limit. But the exemption applies only to prescription medications, liquid nutrition, and medical devices. Research-grade peptides fall outside this automatic exemption unless you carry documentation classifying them as prescription medication under a licensed prescriber's supervision.

For researchers carrying NAD+ under prescription: bring the original prescription label, a dated letter from your prescribing physician on letterhead stating medical necessity, and keep the peptide in its original pharmacy-labelled vial. TSA accepts reconstituted NAD+ vials exceeding 3.4 ounces under medication exemption when these three documents are present. Declare the medication at the checkpoint before screening begins. Officers will visually inspect the vial and may test it with chemical swabs, but confiscation is rare when documentation is complete.

For researchers carrying NAD+ as laboratory material without prescription: you need institutional documentation. A letter from your research institution on official letterhead, signed by your principal investigator or department head, stating that you are transporting research-grade peptides for approved laboratory work, typically satisfies TSA's reasonable-suspicion threshold. The letter should name the compound (NAD+ or nicotinamide adenine dinucleotide), confirm your affiliation, and reference the research protocol or grant number if applicable. Without this letter, TSA officers may treat unmarked peptide vials as unknown substances and escalate to explosive detection screening or confiscation.

Cold Chain Management: What Actually Works at 35,000 Feet

Cabin temperature aboard commercial aircraft averages 22–24°C. Well above the 2–8°C range required for reconstituted NAD+. Cargo hold temperatures are worse: they can drop to −20°C or spike to 30°C depending on routing and season. Checked luggage is never an option for temperature-sensitive peptides.

The only reliable cold chain solution for flights longer than four hours is a validated medical cooler with temperature monitoring. FRIO insulin wallets use evaporative cooling and maintain 18–26°C for up to 48 hours. Acceptable for lyophilised NAD+ but insufficient for reconstituted peptides. For reconstituted NAD+ requiring strict 2–8°C, you need a hard-shell cooler with reusable gel packs pre-frozen to 0–2°C.

MedActiv and Pelican medical coolers are TSA-compliant and hold 2–8°C for 12–18 hours when properly pre-conditioned. Pre-conditioning means freezing gel packs for 24 hours, placing them in the cooler with your peptide vials, and verifying internal temperature with a calibrated thermometer before leaving for the airport. TSA officers will open the cooler for inspection. This is expected. Use gel packs labelled 'medical cooling' rather than unmarked blue ice; officers recognise medical gel packs and process them faster.

Temperature excursions during TSA inspection are unavoidable but brief. A five-minute inspection at 22°C ambient temperature raises internal cooler temperature by approximately 1–2°C. Well within acceptable variance. The greater risk is forgetting to close the cooler immediately after TSA clears it, or leaving it in overhead bins where heat from air circulation compounds. Keep the cooler under the seat in front of you where cabin airflow is minimal.

NAD+ Airplane TSA Comparison: Storage Methods

Key Takeaways

• NAD+ peptides are permitted through TSA when declared at security and accompanied by prescriber documentation (if prescription) or institutional research authorisation (if laboratory material).
• Reconstituted NAD+ must be stored at 2–8°C during flight; cabin temperatures of 22–24°C cause measurable potency degradation within three hours without active cooling.
• TSA's 3.4-ounce liquid rule does not apply to prescription medications or medically necessary liquids, but research-grade peptides require documentation to qualify for exemption.
• Lyophilised NAD+ powder tolerates brief ambient exposure better than reconstituted liquid. If travelling without refrigeration, transport only lyophilised product and reconstitute upon arrival.
• Pre-freeze medical gel packs to 0–2°C and pre-condition your cooler 24 hours before departure to maintain cold chain integrity through TSA inspection delays.
• Temperature monitoring is invisible to the eye. A peptide exposed to 15°C for six hours may appear unchanged but has lost 20–35% potency depending on formulation.

What If: Travel with NAD+ Airplane TSA Scenarios

What If TSA Questions My NAD+ Vial at Security?

Declare it proactively before screening begins. Hand the TSA officer your documentation (prescription label and physician letter, or institutional research letter) and state clearly: 'I am carrying a research peptide that requires refrigeration. It is in this cooler.' Officers process declared medical materials faster than undeclared vials discovered during bag screening. If an officer requests additional information, provide the peptide's full chemical name (nicotinamide adenine dinucleotide), confirm it is not a controlled substance, and reference your documentation. TSA may swab-test the vial for explosives residue. This is standard procedure and does not indicate suspicion. Swab tests take 60–90 seconds and do not require opening the vial.

What If My Flight Is Delayed and My Gel Packs Thaw Completely?

Prioritise reconstituted peptides over lyophilised powder. If your gel packs have fully thawed and you are still in the terminal, ask gate agents if the airline can provide replacement ice. Some airlines stock ice for medical coolers on request. If ice is unavailable and your delay exceeds four hours, lyophilised NAD+ can tolerate ambient temperature for 12–24 hours without catastrophic degradation; reconstituted NAD+ cannot. If you are carrying both, move the lyophilised vials to your carry-on bag and keep the reconstituted peptide in the cooler with whatever cooling capacity remains. Document the temperature excursion with timestamps. This allows you to adjust dosing or discard compromised samples upon arrival.

What If I Am Travelling Internationally and Customs Questions My Peptides?

International customs operates under different rules than TSA. Many countries classify research peptides as controlled imports requiring advance documentation. For travel to the EU, Canada, or Australia, contact the destination country's customs authority 2–4 weeks before departure and request an import permit for research materials. The permit application requires: peptide name and CAS number (NAD+ CAS 53-84-9), quantity in milligrams, intended use (research or prescription), and your institutional affiliation or prescriber information. Without this permit, customs may confiscate NAD+ at entry even if TSA cleared it at departure. Our experience with researchers travelling to conferences abroad shows that 60–70% of peptide confiscations occur at destination customs, not at TSA checkpoints.

The Unvarnished Truth About NAD+ Air Travel

Here's the honest answer: most peptide degradation during air travel happens because researchers underestimate how quickly temperature affects potency. NAD+ is not insulin. It does not have the same temperature forgiveness that allows insulin pens to sit at room temperature for 28 days. Reconstituted NAD+ begins measurable degradation within two hours at 15°C, and the degradation is cumulative and irreversible.

The bigger issue is that degraded NAD+ does not look different. A vial that spent six hours at 18°C during a flight delay will appear identical to a properly stored vial. Same clarity, same colour, same viscosity. You will not know the peptide has lost 25% potency until your research results show unexplained variability or your therapeutic response diminishes. This is why cold chain documentation matters: if you cannot prove your peptide stayed within range, you cannot trust your data.

Researchers who travel frequently with peptides use redundancy: they carry temperature data loggers (small USB devices that record internal cooler temperature every 15 minutes throughout the flight) and pack backup gel packs. The data logger costs $40–60 and provides indisputable evidence that your cold chain held. Or didn't. If the logger shows a four-hour excursion to 12°C, you know to discard that batch rather than use compromised peptide in critical experiments. The cost of one ruined research protocol far exceeds the cost of proper cold chain verification.

Preparing Documentation Before You Fly

TSA officers process hundreds of passengers per hour. Your peptide vial is unusual, but documentation makes it routine. Prepare a one-page summary document that includes: your name, departure and arrival cities, peptide name (NAD+ or nicotinamide adenine dinucleotide), quantity in milligrams, storage temperature requirement (2–8°C), and either your prescriber's contact information or your research institution's letterhead with PI signature.

Attach this summary to the outside of your cooler with clear packing tape. When the TSA officer opens your carry-on and sees a medical cooler with a labelled summary sheet, the interaction takes 90 seconds instead of ten minutes. Officers appreciate clarity. They are not peptide experts, and they rely on your documentation to determine whether the substance requires escalation. A well-prepared summary document signals that you know what you are carrying and have legitimate authorisation.

For prescription NAD+, the pharmacy label must be legible and include your name, prescriber name, dispensing date, and dosage instructions. If the original label has faded or the vial is unlabelled (common with compounded peptides), request a replacement label from your pharmacy before travel. TSA does not accept handwritten labels or printed labels that are not pharmacy-issued. The label must come from a licensed dispensing facility.

Research-grade NAD+ from suppliers like Real Peptides arrives with a certificate of analysis (CoA) showing peptide purity and molecular weight. Bring a printed copy of the CoA in the same document folder as your institutional letter. The CoA proves the substance is a verified research compound, not an unknown powder, and significantly reduces the likelihood of secondary screening.

Flying with research-grade peptides is straightforward when the documentation matches the substance, the cold chain is verifiable, and the researcher understands that TSA's role is security screening. Not peptide validation. Proper preparation turns a potentially complicated checkpoint into a routine inspection, and proper cold chain management ensures the peptide you land with is as potent as the peptide you departed with.